Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts

The Journal of Antimicrobial Chemotherapy
Y W MillerW J Cunliffe

Abstract

The selection of a predominantly resistant staphylococcal skin flora in acne patients during antibiotic treatment has been extensively documented. This study sought to determine whether antibiotic therapy for acne had any effect on skin carriage of resistant coagulase-negative staphylococci (CNS) by close contacts of treated patients. Bacterial samples were obtained using a scrub wash technique from facial skin of 41 contacts (parents, siblings or partners) of patients who had been treated with at least three different antibiotics over a minimum period of 2 years. Samples were also obtained from 41 control subjects who had no known contact with any antibiotic treated acne patient. None of the contacts or controls had received any antibiotic therapy in the preceding two years. The number, percentage and prevalence of CNS resistant to each of seven antibiotics was estimated by plating serial ten-fold dilutions of wash fluid directly onto antibiotic-containing and antibiotic-free medium. Significantly more contacts than controls carried strains resistant to erythromycin, clindamycin, fusidic acid, trimethoprim and chloramphenicol as well as more multiply resistant strains (P < 0.05, chi 2). The number and percentage of staphylococ...Continue Reading

Citations

Mar 14, 2013·Archives of Microbiology·Angela M Alicea-SerranoMaria G Dominguez-Bello
Nov 30, 2000·Current Infectious Disease Reports·L R Baden, B I Eisenstein
Mar 26, 1999·The New Zealand Medical Journal·B Conlon
Aug 7, 2003·The Lancet Infectious Diseases·Allison E Aiello, Elaine Larson
Dec 4, 2004·Nature Medicine·Stuart B Levy, Bonnie Marshall
May 8, 1998·The New England Journal of Medicine·S B Levy
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D Steinke, P Davey
Oct 1, 2011·Journal of the Royal Society, Interface·Joseph N S EisenbergJames Trostle
May 14, 1998·Australian Veterinary Journal·M D Barton
Feb 14, 2013·MBio·Stuart B Levy, Bonnie M Marshall
Jan 26, 2013·PloS One·Hermine V MkrtchyanRonald R Cutler
Mar 15, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·John Kraft, Anatoli Freiman
Mar 27, 2016·Dermatologic Clinics·Alison M Layton
Feb 15, 2011·Infectious Disease Clinics of North America·Courtney Hebert, Stephen G Weber
Jul 14, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S B Levy
May 7, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D Guillemot
Apr 14, 2007·Dermatologic Clinics·James Q Del Rosso, James J Leyden
Feb 6, 2007·Journal of the American Academy of Dermatology·John S StraussUNKNOWN American Academy of Dermatology/American Academy of Dermatology Association
Jan 14, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·P Y BaşakA G Ozseven
Feb 26, 2015·The International Journal of Pharmacy Practice·Attila AltinerAlike van der Velden
Jun 26, 2014·International Journal of Dermatology·Pınar OzuguzSemsettin Karaca
Nov 24, 2004·Clinics in Dermatology·Andreas Katsambas, Anastasia Papakonstantinou
Sep 29, 2004·The Lancet Infectious Diseases·Stephanie J Dancer
Mar 15, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tse-Ying LiuDean-Mo Liu
Jan 18, 1997·Lancet·P M Hawkey
Sep 17, 2005·Journal of the European Academy of Dermatology and Venereology : JEADV·G Perera, R Hay
Dec 16, 2006·The Journal of Dermatology·Cağri ErginBerna S Erdoğan
Jan 27, 2018·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Miriam SanterAlison M Layton
Apr 27, 2002·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·A Schnuch
Aug 16, 2002·American Journal of Clinical Dermatology·Keith T Holland, Richard A Bojar
Apr 12, 2003·American Journal of Clinical Dermatology·Hiok-Hee Tan
Aug 10, 2017·Frontiers in Microbiology·Angela E Ryan-KewleyRonald A Dixon
Oct 28, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E BatardE Montassier
Dec 2, 2020·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Duncan PlattMiriam Santer
Apr 17, 2020·IScience·Alejandra Rodríguez-VerdugoPamela Yeh
Apr 14, 2021·International Journal of Dermatology·David M Weiner, William D James

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.